nodes	percent_of_prediction	percent_of_DWPC	metapath
Risperidone—CYP3A4—bone cancer	0.514	1	CbGaD
Risperidone—HTR1B—dura mater—bone cancer	0.0158	0.178	CbGeAlD
Risperidone—HTR1D—dura mater—bone cancer	0.0153	0.172	CbGeAlD
Risperidone—HTR1B—trigeminal nerve—bone cancer	0.00679	0.0763	CbGeAlD
Risperidone—HTR1D—trigeminal nerve—bone cancer	0.00658	0.0739	CbGeAlD
Risperidone—HRH1—nose—bone cancer	0.00499	0.056	CbGeAlD
Risperidone—HTR1B—cranial nerve—bone cancer	0.00484	0.0544	CbGeAlD
Risperidone—HTR1D—cranial nerve—bone cancer	0.00469	0.0527	CbGeAlD
Risperidone—HTR7—cranial nerve—bone cancer	0.00373	0.042	CbGeAlD
Risperidone—HTR2A—trigeminal nerve—bone cancer	0.00327	0.0367	CbGeAlD
Risperidone—HTR2A—cranial nerve—bone cancer	0.00233	0.0262	CbGeAlD
Risperidone—HTR2A—vertebral column—bone cancer	0.00228	0.0257	CbGeAlD
Risperidone—Paliperidone—CYP3A4—bone cancer	0.002	0.589	CrCbGaD
Risperidone—HTR2A—hindlimb—bone cancer	0.00196	0.022	CbGeAlD
Risperidone—HTR2A—appendage—bone cancer	0.00168	0.0189	CbGeAlD
Risperidone—Iloperidone—CYP3A4—bone cancer	0.0014	0.412	CrCbGaD
Risperidone—H1F0—connective tissue—bone cancer	0.00125	0.014	CbGeAlD
Risperidone—HTR1D—connective tissue—bone cancer	0.000967	0.0109	CbGeAlD
Risperidone—H1F0—tendon—bone cancer	0.000858	0.00964	CbGeAlD
Risperidone—H1F0—bone marrow—bone cancer	0.000831	0.00934	CbGeAlD
Risperidone—H1F0—spinal cord—bone cancer	0.000828	0.0093	CbGeAlD
Risperidone—HTR7—connective tissue—bone cancer	0.00077	0.00866	CbGeAlD
Risperidone—HTR1B—spinal cord—bone cancer	0.000662	0.00744	CbGeAlD
Risperidone—HTR2C—spinal cord—bone cancer	0.000635	0.00713	CbGeAlD
Risperidone—HTR2B—tendon—bone cancer	0.000618	0.00695	CbGeAlD
Risperidone—HRH1—connective tissue—bone cancer	0.000575	0.00646	CbGeAlD
Risperidone—ADRA2A—connective tissue—bone cancer	0.000565	0.00635	CbGeAlD
Risperidone—HTR1A—spinal cord—bone cancer	0.000534	0.006	CbGeAlD
Risperidone—HTR7—tendon—bone cancer	0.00053	0.00595	CbGeAlD
Risperidone—HTR7—spinal cord—bone cancer	0.000511	0.00574	CbGeAlD
Risperidone—ADRA2C—tendon—bone cancer	0.000487	0.00547	CbGeAlD
Risperidone—HTR2A—connective tissue—bone cancer	0.00048	0.0054	CbGeAlD
Risperidone—KCNH2—bone marrow—bone cancer	0.000478	0.00537	CbGeAlD
Risperidone—KCNH2—spinal cord—bone cancer	0.000476	0.00535	CbGeAlD
Risperidone—ADRA2C—spinal cord—bone cancer	0.000469	0.00527	CbGeAlD
Risperidone—HRH1—tendon—bone cancer	0.000395	0.00444	CbGeAlD
Risperidone—ADRA2A—tendon—bone cancer	0.000388	0.00436	CbGeAlD
Risperidone—ADRA2A—spinal cord—bone cancer	0.000375	0.00421	CbGeAlD
Risperidone—HTR2A—tendon—bone cancer	0.00033	0.00371	CbGeAlD
Risperidone—HTR2A—spinal cord—bone cancer	0.000319	0.00358	CbGeAlD
Risperidone—ABCB1—bone marrow—bone cancer	0.00021	0.00236	CbGeAlD
Risperidone—ABCB1—spinal cord—bone cancer	0.000209	0.00235	CbGeAlD
Risperidone—Conjunctivitis—Doxorubicin—bone cancer	0.000201	0.000699	CcSEcCtD
Risperidone—Hepatitis—Epirubicin—bone cancer	0.000201	0.000697	CcSEcCtD
Risperidone—Haemorrhage—Epirubicin—bone cancer	0.000201	0.000697	CcSEcCtD
Risperidone—Eye disorder—Methotrexate—bone cancer	0.000201	0.000696	CcSEcCtD
Risperidone—Tinnitus—Methotrexate—bone cancer	0.0002	0.000695	CcSEcCtD
Risperidone—Hypoaesthesia—Epirubicin—bone cancer	0.0002	0.000694	CcSEcCtD
Risperidone—Asthenia—Cisplatin—bone cancer	0.0002	0.000692	CcSEcCtD
Risperidone—Pharyngitis—Epirubicin—bone cancer	0.0002	0.000692	CcSEcCtD
Risperidone—Cardiac disorder—Methotrexate—bone cancer	0.000199	0.000692	CcSEcCtD
Risperidone—Sweating—Doxorubicin—bone cancer	0.000199	0.000689	CcSEcCtD
Risperidone—Urinary tract disorder—Epirubicin—bone cancer	0.000199	0.000689	CcSEcCtD
Risperidone—Oedema peripheral—Epirubicin—bone cancer	0.000198	0.000687	CcSEcCtD
Risperidone—Haematuria—Doxorubicin—bone cancer	0.000198	0.000685	CcSEcCtD
Risperidone—Connective tissue disorder—Epirubicin—bone cancer	0.000198	0.000685	CcSEcCtD
Risperidone—Urethral disorder—Epirubicin—bone cancer	0.000197	0.000684	CcSEcCtD
Risperidone—Hepatobiliary disease—Doxorubicin—bone cancer	0.000196	0.00068	CcSEcCtD
Risperidone—Epistaxis—Doxorubicin—bone cancer	0.000195	0.000678	CcSEcCtD
Risperidone—Angiopathy—Methotrexate—bone cancer	0.000195	0.000676	CcSEcCtD
Risperidone—Sinusitis—Doxorubicin—bone cancer	0.000194	0.000674	CcSEcCtD
Risperidone—Immune system disorder—Methotrexate—bone cancer	0.000194	0.000673	CcSEcCtD
Risperidone—Visual impairment—Epirubicin—bone cancer	0.000194	0.000672	CcSEcCtD
Risperidone—Mediastinal disorder—Methotrexate—bone cancer	0.000194	0.000672	CcSEcCtD
Risperidone—Agranulocytosis—Doxorubicin—bone cancer	0.000193	0.000671	CcSEcCtD
Risperidone—Chills—Methotrexate—bone cancer	0.000193	0.000669	CcSEcCtD
Risperidone—Diarrhoea—Cisplatin—bone cancer	0.00019	0.00066	CcSEcCtD
Risperidone—Erythema multiforme—Epirubicin—bone cancer	0.00019	0.000659	CcSEcCtD
Risperidone—Alopecia—Methotrexate—bone cancer	0.00019	0.000658	CcSEcCtD
Risperidone—Bradycardia—Doxorubicin—bone cancer	0.000189	0.000657	CcSEcCtD
Risperidone—Mental disorder—Methotrexate—bone cancer	0.000188	0.000653	CcSEcCtD
Risperidone—Eye disorder—Epirubicin—bone cancer	0.000188	0.000652	CcSEcCtD
Risperidone—Tinnitus—Epirubicin—bone cancer	0.000187	0.00065	CcSEcCtD
Risperidone—Malnutrition—Methotrexate—bone cancer	0.000187	0.000649	CcSEcCtD
Risperidone—Erythema—Methotrexate—bone cancer	0.000187	0.000649	CcSEcCtD
Risperidone—Haemoglobin—Doxorubicin—bone cancer	0.000187	0.000648	CcSEcCtD
Risperidone—Cardiac disorder—Epirubicin—bone cancer	0.000187	0.000647	CcSEcCtD
Risperidone—Flushing—Epirubicin—bone cancer	0.000187	0.000647	CcSEcCtD
Risperidone—Rhinitis—Doxorubicin—bone cancer	0.000187	0.000647	CcSEcCtD
Risperidone—Hepatitis—Doxorubicin—bone cancer	0.000186	0.000645	CcSEcCtD
Risperidone—Haemorrhage—Doxorubicin—bone cancer	0.000186	0.000645	CcSEcCtD
Risperidone—Hypoaesthesia—Doxorubicin—bone cancer	0.000185	0.000642	CcSEcCtD
Risperidone—Pharyngitis—Doxorubicin—bone cancer	0.000185	0.00064	CcSEcCtD
Risperidone—Urinary tract disorder—Doxorubicin—bone cancer	0.000184	0.000637	CcSEcCtD
Risperidone—Oedema peripheral—Doxorubicin—bone cancer	0.000183	0.000636	CcSEcCtD
Risperidone—Dysgeusia—Methotrexate—bone cancer	0.000183	0.000635	CcSEcCtD
Risperidone—Connective tissue disorder—Doxorubicin—bone cancer	0.000183	0.000634	CcSEcCtD
Risperidone—Angiopathy—Epirubicin—bone cancer	0.000182	0.000633	CcSEcCtD
Risperidone—Urethral disorder—Doxorubicin—bone cancer	0.000182	0.000632	CcSEcCtD
Risperidone—Immune system disorder—Epirubicin—bone cancer	0.000182	0.00063	CcSEcCtD
Risperidone—Mediastinal disorder—Epirubicin—bone cancer	0.000181	0.000628	CcSEcCtD
Risperidone—Back pain—Methotrexate—bone cancer	0.000181	0.000627	CcSEcCtD
Risperidone—Chills—Epirubicin—bone cancer	0.00018	0.000626	CcSEcCtD
Risperidone—Arrhythmia—Epirubicin—bone cancer	0.00018	0.000623	CcSEcCtD
Risperidone—Visual impairment—Doxorubicin—bone cancer	0.000179	0.000622	CcSEcCtD
Risperidone—Alopecia—Epirubicin—bone cancer	0.000178	0.000616	CcSEcCtD
Risperidone—Vomiting—Cisplatin—bone cancer	0.000177	0.000613	CcSEcCtD
Risperidone—Vision blurred—Methotrexate—bone cancer	0.000176	0.000611	CcSEcCtD
Risperidone—Mental disorder—Epirubicin—bone cancer	0.000176	0.000611	CcSEcCtD
Risperidone—Erythema multiforme—Doxorubicin—bone cancer	0.000176	0.00061	CcSEcCtD
Risperidone—Rash—Cisplatin—bone cancer	0.000175	0.000608	CcSEcCtD
Risperidone—Dermatitis—Cisplatin—bone cancer	0.000175	0.000608	CcSEcCtD
Risperidone—Erythema—Epirubicin—bone cancer	0.000175	0.000607	CcSEcCtD
Risperidone—Malnutrition—Epirubicin—bone cancer	0.000175	0.000607	CcSEcCtD
Risperidone—Eye disorder—Doxorubicin—bone cancer	0.000174	0.000603	CcSEcCtD
Risperidone—Ill-defined disorder—Methotrexate—bone cancer	0.000174	0.000602	CcSEcCtD
Risperidone—Tinnitus—Doxorubicin—bone cancer	0.000173	0.000602	CcSEcCtD
Risperidone—Anaemia—Methotrexate—bone cancer	0.000173	0.0006	CcSEcCtD
Risperidone—Cardiac disorder—Doxorubicin—bone cancer	0.000173	0.000599	CcSEcCtD
Risperidone—Flushing—Doxorubicin—bone cancer	0.000173	0.000599	CcSEcCtD
Risperidone—Flatulence—Epirubicin—bone cancer	0.000172	0.000598	CcSEcCtD
Risperidone—Tension—Epirubicin—bone cancer	0.000172	0.000596	CcSEcCtD
Risperidone—Dysgeusia—Epirubicin—bone cancer	0.000171	0.000594	CcSEcCtD
Risperidone—Nervousness—Epirubicin—bone cancer	0.00017	0.00059	CcSEcCtD
Risperidone—Back pain—Epirubicin—bone cancer	0.000169	0.000587	CcSEcCtD
Risperidone—Angiopathy—Doxorubicin—bone cancer	0.000169	0.000585	CcSEcCtD
Risperidone—Malaise—Methotrexate—bone cancer	0.000169	0.000585	CcSEcCtD
Risperidone—Muscle spasms—Epirubicin—bone cancer	0.000168	0.000584	CcSEcCtD
Risperidone—Immune system disorder—Doxorubicin—bone cancer	0.000168	0.000583	CcSEcCtD
Risperidone—Vertigo—Methotrexate—bone cancer	0.000168	0.000583	CcSEcCtD
Risperidone—Mediastinal disorder—Doxorubicin—bone cancer	0.000168	0.000581	CcSEcCtD
Risperidone—Leukopenia—Methotrexate—bone cancer	0.000167	0.000581	CcSEcCtD
Risperidone—Chills—Doxorubicin—bone cancer	0.000167	0.000579	CcSEcCtD
Risperidone—Arrhythmia—Doxorubicin—bone cancer	0.000166	0.000576	CcSEcCtD
Risperidone—Nausea—Cisplatin—bone cancer	0.000165	0.000573	CcSEcCtD
Risperidone—Vision blurred—Epirubicin—bone cancer	0.000165	0.000572	CcSEcCtD
Risperidone—Alopecia—Doxorubicin—bone cancer	0.000164	0.00057	CcSEcCtD
Risperidone—Cough—Methotrexate—bone cancer	0.000163	0.000566	CcSEcCtD
Risperidone—Mental disorder—Doxorubicin—bone cancer	0.000163	0.000565	CcSEcCtD
Risperidone—Ill-defined disorder—Epirubicin—bone cancer	0.000162	0.000563	CcSEcCtD
Risperidone—Convulsion—Methotrexate—bone cancer	0.000162	0.000562	CcSEcCtD
Risperidone—Erythema—Doxorubicin—bone cancer	0.000162	0.000562	CcSEcCtD
Risperidone—Malnutrition—Doxorubicin—bone cancer	0.000162	0.000562	CcSEcCtD
Risperidone—Anaemia—Epirubicin—bone cancer	0.000162	0.000561	CcSEcCtD
Risperidone—Agitation—Epirubicin—bone cancer	0.000161	0.000558	CcSEcCtD
Risperidone—Flatulence—Doxorubicin—bone cancer	0.00016	0.000553	CcSEcCtD
Risperidone—Chest pain—Methotrexate—bone cancer	0.000159	0.000552	CcSEcCtD
Risperidone—Arthralgia—Methotrexate—bone cancer	0.000159	0.000552	CcSEcCtD
Risperidone—Myalgia—Methotrexate—bone cancer	0.000159	0.000552	CcSEcCtD
Risperidone—Tension—Doxorubicin—bone cancer	0.000159	0.000551	CcSEcCtD
Risperidone—Dysgeusia—Doxorubicin—bone cancer	0.000159	0.00055	CcSEcCtD
Risperidone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000158	0.000548	CcSEcCtD
Risperidone—Malaise—Epirubicin—bone cancer	0.000158	0.000547	CcSEcCtD
Risperidone—Discomfort—Methotrexate—bone cancer	0.000157	0.000546	CcSEcCtD
Risperidone—Nervousness—Doxorubicin—bone cancer	0.000157	0.000546	CcSEcCtD
Risperidone—Vertigo—Epirubicin—bone cancer	0.000157	0.000545	CcSEcCtD
Risperidone—Syncope—Epirubicin—bone cancer	0.000157	0.000544	CcSEcCtD
Risperidone—Leukopenia—Epirubicin—bone cancer	0.000157	0.000543	CcSEcCtD
Risperidone—Back pain—Doxorubicin—bone cancer	0.000157	0.000543	CcSEcCtD
Risperidone—Muscle spasms—Doxorubicin—bone cancer	0.000156	0.00054	CcSEcCtD
Risperidone—Palpitations—Epirubicin—bone cancer	0.000155	0.000536	CcSEcCtD
Risperidone—Confusional state—Methotrexate—bone cancer	0.000154	0.000534	CcSEcCtD
Risperidone—Loss of consciousness—Epirubicin—bone cancer	0.000154	0.000534	CcSEcCtD
Risperidone—Cough—Epirubicin—bone cancer	0.000153	0.00053	CcSEcCtD
Risperidone—Anaphylactic shock—Methotrexate—bone cancer	0.000153	0.000529	CcSEcCtD
Risperidone—Vision blurred—Doxorubicin—bone cancer	0.000153	0.000529	CcSEcCtD
Risperidone—Convulsion—Epirubicin—bone cancer	0.000152	0.000526	CcSEcCtD
Risperidone—Infection—Methotrexate—bone cancer	0.000152	0.000526	CcSEcCtD
Risperidone—Hypertension—Epirubicin—bone cancer	0.000151	0.000524	CcSEcCtD
Risperidone—Ill-defined disorder—Doxorubicin—bone cancer	0.00015	0.000521	CcSEcCtD
Risperidone—Nervous system disorder—Methotrexate—bone cancer	0.00015	0.000519	CcSEcCtD
Risperidone—Anaemia—Doxorubicin—bone cancer	0.00015	0.000519	CcSEcCtD
Risperidone—Thrombocytopenia—Methotrexate—bone cancer	0.000149	0.000518	CcSEcCtD
Risperidone—Myalgia—Epirubicin—bone cancer	0.000149	0.000517	CcSEcCtD
Risperidone—Chest pain—Epirubicin—bone cancer	0.000149	0.000517	CcSEcCtD
Risperidone—Arthralgia—Epirubicin—bone cancer	0.000149	0.000517	CcSEcCtD
Risperidone—Agitation—Doxorubicin—bone cancer	0.000149	0.000516	CcSEcCtD
Risperidone—Anxiety—Epirubicin—bone cancer	0.000148	0.000515	CcSEcCtD
Risperidone—Skin disorder—Methotrexate—bone cancer	0.000148	0.000514	CcSEcCtD
Risperidone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000148	0.000513	CcSEcCtD
Risperidone—Hyperhidrosis—Methotrexate—bone cancer	0.000148	0.000512	CcSEcCtD
Risperidone—Discomfort—Epirubicin—bone cancer	0.000147	0.000511	CcSEcCtD
Risperidone—Malaise—Doxorubicin—bone cancer	0.000146	0.000506	CcSEcCtD
Risperidone—Dry mouth—Epirubicin—bone cancer	0.000146	0.000505	CcSEcCtD
Risperidone—Vertigo—Doxorubicin—bone cancer	0.000145	0.000505	CcSEcCtD
Risperidone—Anorexia—Methotrexate—bone cancer	0.000145	0.000505	CcSEcCtD
Risperidone—Syncope—Doxorubicin—bone cancer	0.000145	0.000504	CcSEcCtD
Risperidone—Leukopenia—Doxorubicin—bone cancer	0.000145	0.000503	CcSEcCtD
Risperidone—Confusional state—Epirubicin—bone cancer	0.000144	0.0005	CcSEcCtD
Risperidone—Palpitations—Doxorubicin—bone cancer	0.000143	0.000496	CcSEcCtD
Risperidone—Oedema—Epirubicin—bone cancer	0.000143	0.000495	CcSEcCtD
Risperidone—Anaphylactic shock—Epirubicin—bone cancer	0.000143	0.000495	CcSEcCtD
Risperidone—Hypotension—Methotrexate—bone cancer	0.000143	0.000495	CcSEcCtD
Risperidone—Loss of consciousness—Doxorubicin—bone cancer	0.000142	0.000494	CcSEcCtD
Risperidone—Infection—Epirubicin—bone cancer	0.000142	0.000492	CcSEcCtD
Risperidone—Cough—Doxorubicin—bone cancer	0.000141	0.00049	CcSEcCtD
Risperidone—Shock—Epirubicin—bone cancer	0.000141	0.000487	CcSEcCtD
Risperidone—Convulsion—Doxorubicin—bone cancer	0.00014	0.000487	CcSEcCtD
Risperidone—Nervous system disorder—Epirubicin—bone cancer	0.00014	0.000486	CcSEcCtD
Risperidone—Thrombocytopenia—Epirubicin—bone cancer	0.00014	0.000485	CcSEcCtD
Risperidone—Hypertension—Doxorubicin—bone cancer	0.00014	0.000485	CcSEcCtD
Risperidone—Tachycardia—Epirubicin—bone cancer	0.000139	0.000484	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000139	0.000482	CcSEcCtD
Risperidone—Skin disorder—Epirubicin—bone cancer	0.000139	0.000481	CcSEcCtD
Risperidone—Hyperhidrosis—Epirubicin—bone cancer	0.000138	0.000479	CcSEcCtD
Risperidone—Insomnia—Methotrexate—bone cancer	0.000138	0.000479	CcSEcCtD
Risperidone—Chest pain—Doxorubicin—bone cancer	0.000138	0.000478	CcSEcCtD
Risperidone—Myalgia—Doxorubicin—bone cancer	0.000138	0.000478	CcSEcCtD
Risperidone—Arthralgia—Doxorubicin—bone cancer	0.000138	0.000478	CcSEcCtD
Risperidone—Anxiety—Doxorubicin—bone cancer	0.000137	0.000477	CcSEcCtD
Risperidone—Paraesthesia—Methotrexate—bone cancer	0.000137	0.000475	CcSEcCtD
Risperidone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000137	0.000475	CcSEcCtD
Risperidone—Discomfort—Doxorubicin—bone cancer	0.000136	0.000472	CcSEcCtD
Risperidone—Anorexia—Epirubicin—bone cancer	0.000136	0.000472	CcSEcCtD
Risperidone—Dyspnoea—Methotrexate—bone cancer	0.000136	0.000472	CcSEcCtD
Risperidone—Somnolence—Methotrexate—bone cancer	0.000136	0.000471	CcSEcCtD
Risperidone—Dry mouth—Doxorubicin—bone cancer	0.000135	0.000468	CcSEcCtD
Risperidone—Dyspepsia—Methotrexate—bone cancer	0.000134	0.000466	CcSEcCtD
Risperidone—Hypotension—Epirubicin—bone cancer	0.000133	0.000463	CcSEcCtD
Risperidone—Confusional state—Doxorubicin—bone cancer	0.000133	0.000462	CcSEcCtD
Risperidone—Decreased appetite—Methotrexate—bone cancer	0.000133	0.00046	CcSEcCtD
Risperidone—Anaphylactic shock—Doxorubicin—bone cancer	0.000132	0.000458	CcSEcCtD
Risperidone—Oedema—Doxorubicin—bone cancer	0.000132	0.000458	CcSEcCtD
Risperidone—Gastrointestinal disorder—Methotrexate—bone cancer	0.000132	0.000457	CcSEcCtD
Risperidone—Fatigue—Methotrexate—bone cancer	0.000132	0.000456	CcSEcCtD
Risperidone—Infection—Doxorubicin—bone cancer	0.000131	0.000455	CcSEcCtD
Risperidone—Pain—Methotrexate—bone cancer	0.000131	0.000453	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Epirubicin—bone cancer	0.00013	0.000451	CcSEcCtD
Risperidone—Shock—Doxorubicin—bone cancer	0.00013	0.000451	CcSEcCtD
Risperidone—Nervous system disorder—Doxorubicin—bone cancer	0.00013	0.00045	CcSEcCtD
Risperidone—Thrombocytopenia—Doxorubicin—bone cancer	0.000129	0.000449	CcSEcCtD
Risperidone—Insomnia—Epirubicin—bone cancer	0.000129	0.000448	CcSEcCtD
Risperidone—Tachycardia—Doxorubicin—bone cancer	0.000129	0.000447	CcSEcCtD
Risperidone—Skin disorder—Doxorubicin—bone cancer	0.000128	0.000445	CcSEcCtD
Risperidone—Paraesthesia—Epirubicin—bone cancer	0.000128	0.000445	CcSEcCtD
Risperidone—Hyperhidrosis—Doxorubicin—bone cancer	0.000128	0.000443	CcSEcCtD
Risperidone—Dyspnoea—Epirubicin—bone cancer	0.000127	0.000442	CcSEcCtD
Risperidone—Somnolence—Epirubicin—bone cancer	0.000127	0.00044	CcSEcCtD
Risperidone—Anorexia—Doxorubicin—bone cancer	0.000126	0.000437	CcSEcCtD
Risperidone—Feeling abnormal—Methotrexate—bone cancer	0.000126	0.000436	CcSEcCtD
Risperidone—Dyspepsia—Epirubicin—bone cancer	0.000126	0.000436	CcSEcCtD
Risperidone—Gastrointestinal pain—Methotrexate—bone cancer	0.000125	0.000433	CcSEcCtD
Risperidone—Decreased appetite—Epirubicin—bone cancer	0.000124	0.000431	CcSEcCtD
Risperidone—Hypotension—Doxorubicin—bone cancer	0.000124	0.000428	CcSEcCtD
Risperidone—Gastrointestinal disorder—Epirubicin—bone cancer	0.000123	0.000428	CcSEcCtD
Risperidone—Fatigue—Epirubicin—bone cancer	0.000123	0.000427	CcSEcCtD
Risperidone—Pain—Epirubicin—bone cancer	0.000122	0.000424	CcSEcCtD
Risperidone—Constipation—Epirubicin—bone cancer	0.000122	0.000424	CcSEcCtD
Risperidone—Urticaria—Methotrexate—bone cancer	0.000121	0.000421	CcSEcCtD
Risperidone—Abdominal pain—Methotrexate—bone cancer	0.000121	0.000418	CcSEcCtD
Risperidone—Body temperature increased—Methotrexate—bone cancer	0.000121	0.000418	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.00012	0.000418	CcSEcCtD
Risperidone—Insomnia—Doxorubicin—bone cancer	0.00012	0.000415	CcSEcCtD
Risperidone—Paraesthesia—Doxorubicin—bone cancer	0.000119	0.000412	CcSEcCtD
Risperidone—Dyspnoea—Doxorubicin—bone cancer	0.000118	0.000409	CcSEcCtD
Risperidone—Feeling abnormal—Epirubicin—bone cancer	0.000118	0.000408	CcSEcCtD
Risperidone—Somnolence—Doxorubicin—bone cancer	0.000117	0.000408	CcSEcCtD
Risperidone—Gastrointestinal pain—Epirubicin—bone cancer	0.000117	0.000405	CcSEcCtD
Risperidone—Dyspepsia—Doxorubicin—bone cancer	0.000116	0.000403	CcSEcCtD
Risperidone—Decreased appetite—Doxorubicin—bone cancer	0.000115	0.000398	CcSEcCtD
Risperidone—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000114	0.000396	CcSEcCtD
Risperidone—Fatigue—Doxorubicin—bone cancer	0.000114	0.000395	CcSEcCtD
Risperidone—Urticaria—Epirubicin—bone cancer	0.000113	0.000394	CcSEcCtD
Risperidone—Pain—Doxorubicin—bone cancer	0.000113	0.000392	CcSEcCtD
Risperidone—Constipation—Doxorubicin—bone cancer	0.000113	0.000392	CcSEcCtD
Risperidone—Abdominal pain—Epirubicin—bone cancer	0.000113	0.000392	CcSEcCtD
Risperidone—Body temperature increased—Epirubicin—bone cancer	0.000113	0.000392	CcSEcCtD
Risperidone—Hypersensitivity—Methotrexate—bone cancer	0.000112	0.00039	CcSEcCtD
Risperidone—Asthenia—Methotrexate—bone cancer	0.00011	0.00038	CcSEcCtD
Risperidone—Feeling abnormal—Doxorubicin—bone cancer	0.000109	0.000378	CcSEcCtD
Risperidone—Gastrointestinal pain—Doxorubicin—bone cancer	0.000108	0.000375	CcSEcCtD
Risperidone—Pruritus—Methotrexate—bone cancer	0.000108	0.000375	CcSEcCtD
Risperidone—Hypersensitivity—Epirubicin—bone cancer	0.000105	0.000365	CcSEcCtD
Risperidone—Urticaria—Doxorubicin—bone cancer	0.000105	0.000364	CcSEcCtD
Risperidone—Abdominal pain—Doxorubicin—bone cancer	0.000104	0.000362	CcSEcCtD
Risperidone—Body temperature increased—Doxorubicin—bone cancer	0.000104	0.000362	CcSEcCtD
Risperidone—Diarrhoea—Methotrexate—bone cancer	0.000104	0.000362	CcSEcCtD
Risperidone—Asthenia—Epirubicin—bone cancer	0.000102	0.000355	CcSEcCtD
Risperidone—Pruritus—Epirubicin—bone cancer	0.000101	0.00035	CcSEcCtD
Risperidone—Dizziness—Methotrexate—bone cancer	0.000101	0.00035	CcSEcCtD
Risperidone—Diarrhoea—Epirubicin—bone cancer	9.77e-05	0.000339	CcSEcCtD
Risperidone—Hypersensitivity—Doxorubicin—bone cancer	9.74e-05	0.000338	CcSEcCtD
Risperidone—Vomiting—Methotrexate—bone cancer	9.7e-05	0.000337	CcSEcCtD
Risperidone—Rash—Methotrexate—bone cancer	9.62e-05	0.000334	CcSEcCtD
Risperidone—Dermatitis—Methotrexate—bone cancer	9.62e-05	0.000333	CcSEcCtD
Risperidone—Headache—Methotrexate—bone cancer	9.56e-05	0.000332	CcSEcCtD
Risperidone—Asthenia—Doxorubicin—bone cancer	9.48e-05	0.000329	CcSEcCtD
Risperidone—Dizziness—Epirubicin—bone cancer	9.45e-05	0.000328	CcSEcCtD
Risperidone—Pruritus—Doxorubicin—bone cancer	9.35e-05	0.000324	CcSEcCtD
Risperidone—Vomiting—Epirubicin—bone cancer	9.08e-05	0.000315	CcSEcCtD
Risperidone—Nausea—Methotrexate—bone cancer	9.07e-05	0.000314	CcSEcCtD
Risperidone—Diarrhoea—Doxorubicin—bone cancer	9.04e-05	0.000314	CcSEcCtD
Risperidone—Rash—Epirubicin—bone cancer	9.01e-05	0.000312	CcSEcCtD
Risperidone—Dermatitis—Epirubicin—bone cancer	9e-05	0.000312	CcSEcCtD
Risperidone—Headache—Epirubicin—bone cancer	8.95e-05	0.00031	CcSEcCtD
Risperidone—Dizziness—Doxorubicin—bone cancer	8.74e-05	0.000303	CcSEcCtD
Risperidone—Nausea—Epirubicin—bone cancer	8.48e-05	0.000294	CcSEcCtD
Risperidone—Vomiting—Doxorubicin—bone cancer	8.4e-05	0.000291	CcSEcCtD
Risperidone—Rash—Doxorubicin—bone cancer	8.33e-05	0.000289	CcSEcCtD
Risperidone—Dermatitis—Doxorubicin—bone cancer	8.33e-05	0.000289	CcSEcCtD
Risperidone—Headache—Doxorubicin—bone cancer	8.28e-05	0.000287	CcSEcCtD
Risperidone—Nausea—Doxorubicin—bone cancer	7.85e-05	0.000272	CcSEcCtD
Risperidone—CYP3A7—Metabolism—CYP3A4—bone cancer	3.01e-05	0.000285	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—ATF1—bone cancer	2.97e-05	0.000282	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—SMO—bone cancer	2.95e-05	0.000279	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—NT5C3A—bone cancer	2.94e-05	0.000279	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—IL3—bone cancer	2.94e-05	0.000278	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—CYP3A4—bone cancer	2.93e-05	0.000277	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—TGFBR2—bone cancer	2.92e-05	0.000276	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—SMO—bone cancer	2.9e-05	0.000275	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—IL3—bone cancer	2.9e-05	0.000275	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—TGFBR2—bone cancer	2.9e-05	0.000275	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—GNA11—bone cancer	2.89e-05	0.000274	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—TGFBR2—bone cancer	2.84e-05	0.000269	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—DHFR—bone cancer	2.8e-05	0.000266	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—TGFBR2—bone cancer	2.79e-05	0.000265	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—GNA11—bone cancer	2.79e-05	0.000264	CbGpPWpGaD
Risperidone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	2.77e-05	0.000263	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—GNA11—bone cancer	2.77e-05	0.000263	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—ENO2—bone cancer	2.77e-05	0.000262	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—IGF1R—bone cancer	2.74e-05	0.00026	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—IGF1R—bone cancer	2.73e-05	0.000258	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—GNA11—bone cancer	2.7e-05	0.000256	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—ATF1—bone cancer	2.69e-05	0.000254	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—SMO—bone cancer	2.68e-05	0.000254	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—IGF1R—bone cancer	2.67e-05	0.000253	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—TGFBR2—bone cancer	2.67e-05	0.000253	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—GNA11—bone cancer	2.66e-05	0.000252	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—SMO—bone cancer	2.63e-05	0.000249	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—SMO—bone cancer	2.63e-05	0.000249	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—IGF1R—bone cancer	2.63e-05	0.000249	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—GNA11—bone cancer	2.62e-05	0.000248	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—IL3—bone cancer	2.62e-05	0.000248	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—ATF1—bone cancer	2.59e-05	0.000246	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—ATF1—bone cancer	2.58e-05	0.000244	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—SMO—bone cancer	2.58e-05	0.000244	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—GSTP1—bone cancer	2.58e-05	0.000244	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—DHFR—bone cancer	2.57e-05	0.000243	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—IL3—bone cancer	2.53e-05	0.000239	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—IL3—bone cancer	2.51e-05	0.000238	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—TGFBR2—bone cancer	2.51e-05	0.000238	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—ATF1—bone cancer	2.51e-05	0.000238	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—IGF1R—bone cancer	2.51e-05	0.000238	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—GSTP1—bone cancer	2.5e-05	0.000237	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—TGFBR2—bone cancer	2.48e-05	0.000235	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—ATF1—bone cancer	2.47e-05	0.000234	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—GNA11—bone cancer	2.45e-05	0.000232	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—IL3—bone cancer	2.45e-05	0.000232	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—GNA11—bone cancer	2.41e-05	0.000228	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—IL3—bone cancer	2.41e-05	0.000228	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—GNA11—bone cancer	2.4e-05	0.000228	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—GNA11—bone cancer	2.4e-05	0.000228	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—SMO—bone cancer	2.4e-05	0.000227	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—CYP3A4—bone cancer	2.38e-05	0.000225	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—IGF1R—bone cancer	2.37e-05	0.000224	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—GNA11—bone cancer	2.36e-05	0.000223	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—IGF1R—bone cancer	2.33e-05	0.000221	CbGpPWpGaD
Risperidone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	2.33e-05	0.000221	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—ATF1—bone cancer	2.28e-05	0.000216	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—TGFBR2—bone cancer	2.24e-05	0.000212	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—ATF1—bone cancer	2.24e-05	0.000212	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—ATF1—bone cancer	2.23e-05	0.000212	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—IL3—bone cancer	2.22e-05	0.00021	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—ATF1—bone cancer	2.19e-05	0.000208	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—GNA11—bone cancer	2.19e-05	0.000208	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—IL3—bone cancer	2.18e-05	0.000207	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—IL3—bone cancer	2.18e-05	0.000206	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—CYP3A4—bone cancer	2.18e-05	0.000206	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—TGFBR2—bone cancer	2.16e-05	0.000205	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—TGFBR2—bone cancer	2.15e-05	0.000204	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—IL3—bone cancer	2.14e-05	0.000203	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—IGF1R—bone cancer	2.11e-05	0.0002	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—TGFBR2—bone cancer	2.09e-05	0.000198	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—ENO2—bone cancer	2.09e-05	0.000198	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—TGFBR2—bone cancer	2.06e-05	0.000195	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—ATF1—bone cancer	2.04e-05	0.000193	CbGpPWpGaD
Risperidone—ADRA2B—Hemostasis—TP53—bone cancer	2.04e-05	0.000193	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—IGF1R—bone cancer	2.03e-05	0.000193	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—GSTP1—bone cancer	2.03e-05	0.000193	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—IGF1R—bone cancer	2.02e-05	0.000192	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—KIT—bone cancer	1.99e-05	0.000189	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—IL3—bone cancer	1.99e-05	0.000188	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—KIT—bone cancer	1.98e-05	0.000187	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—ENO2—bone cancer	1.97e-05	0.000187	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—IGF1R—bone cancer	1.97e-05	0.000186	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—DHFR—bone cancer	1.94e-05	0.000184	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—IGF1R—bone cancer	1.94e-05	0.000184	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—KIT—bone cancer	1.94e-05	0.000183	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—KIT—bone cancer	1.91e-05	0.000181	CbGpPWpGaD
Risperidone—ADRA2C—Hemostasis—TP53—bone cancer	1.9e-05	0.00018	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—TGFBR2—bone cancer	1.9e-05	0.00018	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—BRAF—bone cancer	1.87e-05	0.000177	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—TGFBR2—bone cancer	1.87e-05	0.000177	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—TGFBR2—bone cancer	1.86e-05	0.000177	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—GSTP1—bone cancer	1.86e-05	0.000176	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—BRAF—bone cancer	1.86e-05	0.000176	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—TGFBR2—bone cancer	1.83e-05	0.000173	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—DHFR—bone cancer	1.83e-05	0.000173	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—BRAF—bone cancer	1.82e-05	0.000172	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—KIT—bone cancer	1.82e-05	0.000172	CbGpPWpGaD
Risperidone—HTR7—Signaling by GPCR—EGFR—bone cancer	1.81e-05	0.000172	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—GNA11—bone cancer	1.81e-05	0.000172	CbGpPWpGaD
Risperidone—HTR1D—Signaling by GPCR—EGFR—bone cancer	1.8e-05	0.000171	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—BRAF—bone cancer	1.79e-05	0.00017	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—IGF1R—bone cancer	1.79e-05	0.000169	CbGpPWpGaD
Risperidone—HTR1B—Signaling by GPCR—EGFR—bone cancer	1.76e-05	0.000167	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—IGF1R—bone cancer	1.76e-05	0.000166	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—IGF1R—bone cancer	1.75e-05	0.000166	CbGpPWpGaD
Risperidone—DRD4—Signaling by GPCR—EGFR—bone cancer	1.74e-05	0.000164	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—IGF1R—bone cancer	1.72e-05	0.000163	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—KIT—bone cancer	1.72e-05	0.000163	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—BRAF—bone cancer	1.71e-05	0.000162	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—GNA11—bone cancer	1.71e-05	0.000162	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—TGFBR2—bone cancer	1.7e-05	0.000161	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—KIT—bone cancer	1.69e-05	0.00016	CbGpPWpGaD
Risperidone—HTR2B—Signaling by GPCR—EGFR—bone cancer	1.66e-05	0.000157	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—CYP3A4—bone cancer	1.64e-05	0.000156	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—BRAF—bone cancer	1.61e-05	0.000153	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—IGF1R—bone cancer	1.6e-05	0.000151	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—BRAF—bone cancer	1.59e-05	0.000151	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—MDM2—bone cancer	1.57e-05	0.000149	CbGpPWpGaD
Risperidone—DRD1—Signaling by GPCR—EGFR—bone cancer	1.56e-05	0.000148	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—MDM2—bone cancer	1.56e-05	0.000148	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—CYP3A4—bone cancer	1.55e-05	0.000147	CbGpPWpGaD
Risperidone—ADRA2A—Hemostasis—TP53—bone cancer	1.55e-05	0.000146	CbGpPWpGaD
Risperidone—DRD3—Signaling by GPCR—EGFR—bone cancer	1.54e-05	0.000146	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—KIT—bone cancer	1.53e-05	0.000145	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—MDM2—bone cancer	1.53e-05	0.000144	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—MDM2—bone cancer	1.5e-05	0.000142	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—KIT—bone cancer	1.48e-05	0.00014	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—KIT—bone cancer	1.47e-05	0.000139	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—BRAF—bone cancer	1.44e-05	0.000136	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—MDM2—bone cancer	1.43e-05	0.000136	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—KIT—bone cancer	1.43e-05	0.000135	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—GSTP1—bone cancer	1.41e-05	0.000133	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—KIT—bone cancer	1.4e-05	0.000133	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—EGFR—bone cancer	1.39e-05	0.000132	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—BRAF—bone cancer	1.39e-05	0.000131	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—BRAF—bone cancer	1.38e-05	0.000131	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—JUN—bone cancer	1.36e-05	0.000129	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—JUN—bone cancer	1.35e-05	0.000128	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—MDM2—bone cancer	1.35e-05	0.000128	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—EGFR—bone cancer	1.34e-05	0.000127	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—BRAF—bone cancer	1.34e-05	0.000127	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—EGFR—bone cancer	1.34e-05	0.000127	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—PTGS2—bone cancer	1.33e-05	0.000126	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—MDM2—bone cancer	1.33e-05	0.000126	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—MMP9—bone cancer	1.33e-05	0.000126	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—JUN—bone cancer	1.33e-05	0.000126	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—GSTP1—bone cancer	1.32e-05	0.000125	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—BRAF—bone cancer	1.32e-05	0.000125	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—MMP9—bone cancer	1.32e-05	0.000125	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—JUN—bone cancer	1.3e-05	0.000124	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—EGFR—bone cancer	1.3e-05	0.000123	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—PTGS2—bone cancer	1.3e-05	0.000123	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—KIT—bone cancer	1.3e-05	0.000123	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—MMP9—bone cancer	1.29e-05	0.000122	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—ENO2—bone cancer	1.29e-05	0.000122	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—EGFR—bone cancer	1.28e-05	0.000121	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—KIT—bone cancer	1.27e-05	0.000121	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—KIT—bone cancer	1.27e-05	0.00012	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—MMP9—bone cancer	1.27e-05	0.00012	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—KIT—bone cancer	1.25e-05	0.000118	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—JUN—bone cancer	1.25e-05	0.000118	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—BRAF—bone cancer	1.22e-05	0.000115	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—MMP9—bone cancer	1.21e-05	0.000115	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—MDM2—bone cancer	1.2e-05	0.000114	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—BRAF—bone cancer	1.2e-05	0.000113	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—BRAF—bone cancer	1.2e-05	0.000113	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—DHFR—bone cancer	1.19e-05	0.000113	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—EGFR—bone cancer	1.18e-05	0.000112	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—JUN—bone cancer	1.17e-05	0.000111	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—BRAF—bone cancer	1.17e-05	0.000111	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—MDM2—bone cancer	1.16e-05	0.00011	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—EGFR—bone cancer	1.16e-05	0.00011	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—KIT—bone cancer	1.16e-05	0.00011	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—JUN—bone cancer	1.16e-05	0.00011	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—EGFR—bone cancer	1.16e-05	0.00011	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—MDM2—bone cancer	1.16e-05	0.000109	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—MMP9—bone cancer	1.14e-05	0.000108	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—EGFR—bone cancer	1.14e-05	0.000108	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—MMP9—bone cancer	1.13e-05	0.000107	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—MDM2—bone cancer	1.12e-05	0.000107	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—GNA11—bone cancer	1.12e-05	0.000106	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—MDM2—bone cancer	1.11e-05	0.000105	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—BRAF—bone cancer	1.09e-05	0.000103	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—EGFR—bone cancer	1.07e-05	0.000101	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—EGFR—bone cancer	1.06e-05	0.000101	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—EGFR—bone cancer	1.06e-05	0.0001	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—PTGS2—bone cancer	1.05e-05	9.97e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—JUN—bone cancer	1.05e-05	9.91e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—EGFR—bone cancer	1.04e-05	9.87e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—EGFR—bone cancer	1.03e-05	9.72e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—MDM2—bone cancer	1.02e-05	9.66e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—MMP9—bone cancer	1.02e-05	9.64e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—JUN—bone cancer	1.01e-05	9.57e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—JUN—bone cancer	1e-05	9.52e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—MDM2—bone cancer	1e-05	9.51e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—MDM2—bone cancer	1e-05	9.49e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—MDM2—bone cancer	9.83e-06	9.31e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—MMP9—bone cancer	9.82e-06	9.31e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—EGFR—bone cancer	9.79e-06	9.27e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—MMP9—bone cancer	9.77e-06	9.26e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—JUN—bone cancer	9.77e-06	9.26e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—PTGS2—bone cancer	9.65e-06	9.14e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—JUN—bone cancer	9.62e-06	9.11e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—MMP9—bone cancer	9.51e-06	9.01e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—MMP9—bone cancer	9.36e-06	8.86e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—EGFR—bone cancer	9.23e-06	8.75e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—MDM2—bone cancer	9.13e-06	8.65e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—EGFR—bone cancer	9.11e-06	8.63e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—TP53—bone cancer	9e-06	8.52e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—TP53—bone cancer	8.94e-06	8.47e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—JUN—bone cancer	8.87e-06	8.4e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—TP53—bone cancer	8.75e-06	8.29e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—JUN—bone cancer	8.72e-06	8.26e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—JUN—bone cancer	8.71e-06	8.25e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—GSTP1—bone cancer	8.66e-06	8.2e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—MMP9—bone cancer	8.63e-06	8.17e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—TP53—bone cancer	8.61e-06	8.16e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—JUN—bone cancer	8.54e-06	8.09e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—MMP9—bone cancer	8.49e-06	8.04e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—MMP9—bone cancer	8.47e-06	8.02e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—MMP9—bone cancer	8.31e-06	7.87e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—EGFR—bone cancer	8.22e-06	7.79e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—TP53—bone cancer	8.22e-06	7.79e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—EGFR—bone cancer	7.94e-06	7.52e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—JUN—bone cancer	7.94e-06	7.52e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—EGFR—bone cancer	7.9e-06	7.48e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—TP53—bone cancer	7.75e-06	7.34e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—MMP9—bone cancer	7.72e-06	7.32e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—EGFR—bone cancer	7.68e-06	7.28e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—TP53—bone cancer	7.65e-06	7.25e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—EGFR—bone cancer	7.56e-06	7.16e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PTGS2—bone cancer	7.28e-06	6.9e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—EGFR—bone cancer	6.97e-06	6.6e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—TP53—bone cancer	6.91e-06	6.54e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PTGS2—bone cancer	6.86e-06	6.5e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—EGFR—bone cancer	6.86e-06	6.5e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—EGFR—bone cancer	6.84e-06	6.48e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—EGFR—bone cancer	6.72e-06	6.36e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—TP53—bone cancer	6.67e-06	6.32e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—TP53—bone cancer	6.63e-06	6.28e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—TP53—bone cancer	6.45e-06	6.11e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—TP53—bone cancer	6.35e-06	6.01e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—EGFR—bone cancer	6.24e-06	5.91e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—TP53—bone cancer	5.85e-06	5.54e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—TP53—bone cancer	5.76e-06	5.46e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—TP53—bone cancer	5.75e-06	5.44e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—TP53—bone cancer	5.64e-06	5.34e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—TP53—bone cancer	5.24e-06	4.96e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PTGS2—bone cancer	4.49e-06	4.25e-05	CbGpPWpGaD
